Healthtech Startups

Organogenesis is a regenerative medicine company that develops and commercializes products for the advanced wound care and surgical biologics markets, supplying clinicians and their patients. Its product portfolio includes tissue-based therapies such as Apligraf for wound care.

1 investor

ORIA is a Paris-based company, spun off from ENS Paris in 2022, that uses a proprietary mechanical microfluidic platform to extract intact, high-purity functional organelles at industrial scale. Its organelle products serve pharmaceutical companies, biotech firms, and academic institutions for drug discovery, disease modeling, and therapeutic research.

1 investor

Orienda International Hospital is one of Cambodia's larger hospitals providing medical care with a focus on patient satisfaction and modern facilities. The hospital operates with international standards and a team of medical specialists across diverse healthcare needs.

1 investor

Origami Therapeutics is a preclinical-stage biopharmaceutical company developing protein degrader therapeutics to treat neurodegenerative diseases, starting with Huntington's disease. The company uses a proprietary platform that harnesses the body's natural protein disposal system to degrade disease-causing proteins.

1 investor

OriGene develops and supplies genomic and proteomic research tools, including proteins and antibodies built on its proprietary cDNA clone collections, for life science researchers. The company offers a broad catalog of research products used in scientific discovery and diagnostics development.

1 investor

Origin Endoscopy has developed a multipurpose hydrogel designed for rapid bio-adhesion and submucosal injection applications in endoscopy. The technology targets surgical and medical procedure workflows that require biocompatible materials.

1 investor

Origin Medical develops a real-time AI assistant for prenatal ultrasound examinations that aims to shorten exam times, standardize workflows, and reduce errors. It serves sonographers, reading physicians, health systems, and private practices to improve the quality and consistency of prenatal scans and patient care.

1 investor

Origin Sciences applies a hologenomic approach integrating host genetics, epigenetics, and microbiome analysis into a single diagnostic framework for deeper health assessment. The company works with leading institutions and technology providers to develop and scale advanced diagnostic assays for clinical and research applications.

1 investor

Origin provides in-home pediatric speech, occupational, and physical therapy by matching families with local licensed therapists who visit the child's home, with sessions covered by insurance. It also serves as a marketplace for therapists to set their own schedules and build caseloads by choosing clients in their area.

1 investor

Origyn Medical develops minimally invasive gynecological medical devices, including hysteroscopy instruments, cervical health products, women's rehabilitation devices, and gynecological diagnostic tools such as a single-use electronic endoscope. The company serves clinicians and hospitals in the women's health field, with operations in Hangzhou and Hunan, China.

1 investor

Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.

1 investor

Orion Health builds a unified healthcare platform combining digital front-end and care record systems, serving healthcare providers and systems to improve care efficiency and patient outcomes through data insights and machine learning.

1 investor

Orio Therapeutics develops protein-based therapeutics using a technology that modifies therapeutic proteins with a built-in delivery system to control their localization at the injection site, improving efficacy and reducing dosage in regenerative medicine. Its first application is a molecule to protect cardiac muscle following a heart attack (myocardial infarction) by reducing fibrosis and cellular death.

1 investor

emeis (formerly Orpea) operates nursing homes, psychiatric and rehabilitation (SMR) clinics, and home-care services across France, providing personalized medical and social care for elderly, ill, or dependent people. It runs more than 350 establishments in France with around 30,000 staff.

1 investor

Orphalan develops and commercializes innovative therapies for patients with rare diseases, with a focus on unmet medical needs where current treatments are limited or absent. The company has successfully brought trientine tetrahydrochloride (Cuprior®/Cuvrior®) to market for Wilson disease treatment across 30+ countries.

1 investor

Ortho BioMed combines expertise in medicine, engineering, and data science to develop medical technology solutions that improve patient outcomes.

1 investor

1 investor

OrthoPreserve develops a minimally invasive meniscus implant for orthopedic care, designed to address unmet clinical needs in knee surgery. The company is co-founded by orthopedic clinicians and engineers with expertise across R&D, manufacturing, regulatory compliance, and surgical practice.

1 investor

Orthodontic Partners is an orthodontic service organization that partners with orthodontic practices, providing administrative and business support in areas such as accounting, HR, marketing, IT, and reporting, along with a clinical advisory board and shared best practices. It serves orthodontists across the United States who want operational support while retaining focus on patient care.

1 investor

Orthofix develops medical devices and surgical solutions for orthopedic procedures, with a focus on spine surgery and limb reconstruction. The company serves physicians and patients globally and emphasizes product quality, safety, and environmental responsibility in its operations.

1 investor

Orthoforge provides a diagnostic system using ultrasonic analysis and proprietary algorithms to quantify bone and soft tissue healing after injury, delivered through telemedicine without radiation exposure. The technology targets clinicians and orthopedic patients seeking objective, real-time monitoring of fracture recovery.

1 investor

Orthoforge develops ultrasound-based devices that quantify the stages of bone fracture and soft tissue healing without radiation exposure. Its Quantified Ultrasonic Healing analysis is aimed at healthcare professionals and supports remote patient monitoring via telemedicine across settings such as physician offices, hospitals, athletic training rooms, and homes.

1 investor

OrthoFX makes AirFlex, an FDA-cleared clear aligner system that straightens teeth with at least 12 hours of continuous daily wear using a patented elastic polymer for lower force. The company also offers patient financing and provides its aligner products through dental and orthodontic providers.

1 investor

OrthoLoneStar is a management services organization (MSO) that oversees and supports the operations of individual orthopedic practices. It is led by executive and divisional leadership teams.

1 investor